$CATV Category V Biotech New acquisition will significantly benefit CATV shareholders allowing it to become an accelerator in providing the necessary science to get marijuana-based drugs approved by the FDA by integrating Genetic Networks’ advanced genomic technologies. Read more: https://catvbt.com/justice-department-moves-to-reclassify-marijuana-as-less-dangerous-drug-in-historic-policy-shift/ Z